SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001410578-24-000363
Filing Date
2024-03-29
Accepted
2024-03-29 16:11:22
Documents
78

Document Format Files

Seq Description Document Type Size
1 POS AM qnrx-20231231xposam.htm   iXBRL POS AM 2259705
2 EX-23.1 qnrx-20231231xex23d1.htm EX-23.1 5937
3 GRAPHIC qnrx-20231231xposam008.jpg GRAPHIC 5604
  Complete submission text file 0001410578-24-000363.txt   7547363

Data Files

Seq Description Document Type Size
4 EX-101.SCH qnrx-20231231.xsd EX-101.SCH 61914
5 EX-101.CAL qnrx-20231231_cal.xml EX-101.CAL 44814
6 EX-101.DEF qnrx-20231231_def.xml EX-101.DEF 237317
7 EX-101.LAB qnrx-20231231_lab.xml EX-101.LAB 488451
8 EX-101.PRE qnrx-20231231_pre.xml EX-101.PRE 382759
82 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20231231xposam_htm.xml XML 915184
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: POS AM | Act: 33 | File No.: 333-277016 | Film No.: 24804231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)